title: Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.
authors.forename: Kevin H
authors.initials: KH
authors.lastname: Kim
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Horn
authors.forename: Joni
authors.initials: J
authors.lastname: Pharis
authors.forename: Jay
authors.initials: J
authors.lastname: Kincannon
authors.forename: Robert
authors.initials: R
authors.lastname: Jones
authors.forename: Kevin
authors.initials: K
authors.lastname: O'Bryan
authors.forename: Jennifer
authors.initials: J
authors.lastname: Myers
authors.forename: Mayumi
authors.initials: M
authors.lastname: Nakagawa
mesh_terms: D000293:Adolescent; D000328:Adult; D000946:Antigens, Fungal / Q000008:administration & dosage*; D002175:Candida / Q000276:immunology*; D003872:Dermatitis / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000379:methods*; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy* / Q000276:immunology; D055815:Young Adult
chemical_list: D000946:Antigens, Fungal